Cargando…
Hypoglossal Nerve Stimulator Implantation in a Non‐Academic Setting: Two‐Year Result
OBJECTIVES/HYPOTHESIS: Upper Airway Stimulation (UAS) is an FDA approved treatment option for patients with moderate‐to‐severe obstructive sleep apnea (OSA) who could not adhere to continuous positive airway pressure (CPAP). Previous studies have shown UAS reduced apnea‐hypopnea index (AHI) in contr...
Autores principales: | Weeks, Brian, Bao, Gao, Gilbert, Tina M., Emdur, Larry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119799/ https://www.ncbi.nlm.nih.gov/pubmed/30186964 http://dx.doi.org/10.1002/lio2.176 |
Ejemplares similares
-
Implantation of the nyxoah bilateral hypoglossal nerve stimulator for obstructive sleep apnea
por: Lewis, Richard, et al.
Publicado: (2019) -
Hypoglossal nerve stimulator patient usage: Patterns and trends over time
por: Morse, Elliot, et al.
Publicado: (2022) -
Novel Outcome Analysis Tool for Hypoglossal Nerve Stimulator Sensor Lead Function and Comparison by Incision Type (2 Versus 3)
por: Saltagi, Mohamad Z., et al.
Publicado: (2022) -
Insomnia affects patient‐reported outcome in sleep apnea treated with hypoglossal nerve stimulation
por: Steffen, Armin, et al.
Publicado: (2022) -
Comparison of readmission and complication rates between traditional sleep surgery and hypoglossal nerve stimulation
por: Nord, Ryan, et al.
Publicado: (2022)